Background: Hypomagnesemia is frequently encountered in hospitalized patients. The aim of this study was to determine the underlying causes of hypomagnesemia as well as the clinical and biochemical characteristics, and concomitant electrolyte and acid-base abnormalities in patients with decreased serum magnesium (Mg 2+ ) levels in an internal medicine clinic. Methods: We prospectively studied adult patients who, either on admission to our clinic or during their hospitalization, were found to have hypomagnesemia (serum Mg 2+ concentration <1.3 mEq/L). Results: One hundred and seven patients out of 2284 patients had hypomagnesemia. The incidence of hypomagnesemia was 4.7%. Malnutrition, drugs (mainly diuretics and aminoglycosides), respiratory alkalosis, diabetes mellitus, acute tubular necrosis, alcohol consumption and gastrointestinal losses were the main causes of the hypomagnesemia. In the majority of patients (80%), more than one condition may have contributed to the development of hypomagnesemia. Seventy-one patients (66.3%) exhibited at least one additional electrolyte disorder. Hypophosphatemia was the most frequent electrolyte abnormality (31.1%), followed by hypokalemia (26.1%), hyponatremia (21.5%), and hypocalcemia (22%). Seventy-eight patients (72.9%) exhibited pure or mixed acid-base disorders, mainly respiratory alkalosis (20.6%), metabolic acidosis (15.8%), and mixed metabolic alkalosis and respiratory alkalosis (18.7%). Conclusions: Hypomagnesemia in patients hospitalized in an internal medicine clinic was of multifactorial origin. A wide array of concurrent acid-base and electrolyte disorders was evident in this population.
Hypomagnesemia is a frequent electrolyte disorder occurring in up to 12% of hospital inpatients [1] . However, the underlying causes and the incidence of hypomagnesemia range widely depending on the population at risk. Hence, its incidence rises to as high as 60% in patients admitted to intensive care units (ICUs) [2, 3] . Low serum Mg 2+ levels are associated with increased mortality rates in patients hospitalized, not only in ICUs, but also in general wards [4] . Mg 2+ is essential for life, being involved in numerous enzymatic reactions, including ATP use, cell membrane and mitochondrial function as well as protein synthesis. Thus, diverse organ systems are affected by Mg 2+ depletion, but the most clinically significant consequences of hypomagnesemia are ascribed to alterations in the function of excitable membranes in nerve, muscle, and the cardiac conducting system. [5, 6] . It is known that low serum Mg 2+ levels can induce hypokalemia, hypocalcemia, and hypophosphatemia, potentially causing further derangements in neuromuscular and cardiovascular physiology. Consequently, taking into consideration the close link between Mg 2+ , phosphorus (PO 4 3-), calcium (Ca 2+ ) and potassium (K + ) concentrations, the emergence of concurrent electrolyte disorders in patients with hypomagnesemia may be of paramount importance.
In the current prospective study of hypomagnesemic patients (either on admission or during their hospitalization in an internal medicine clinic), we determined the underlying causes of hypomagnesemia as well as the clinical and biochemical characteristics of patients with decreased serum Mg 2+ levels. Also, we describe concomitant electrolyte and acid-base abnormalities encountered in these patients.
Subjects and methods

Patients
Over a period of two years, we prospectively studied non-selected, consecutive, adult patients (over 18 years of age), who, either on admission to our clinic or during their hospitalization, were found to have hypomagnesemia. The study took place in the internal medicine clinic at the University Hospital of Ioannina. To be eligible, patients had to have a serum Mg 2+ concentration <1.3 mEq/L (0.65 mmol/L), at two sequential measurements to exclude potential laboratory errors [7] .
In patients with hypoalbuminemia (serum albumin <40 g/L), corrected serum Mg 2+ was calculated using the formula:
(mEq/L) + 0.01 X (40-albumin g/L) [8] Patients with corrected serum Mg 2+ >1.3 mEq/L were excluded from the study. In all cases, a detailed medical history was obtained with emphasis on dietary intake, alcohol consumption, drug administration, and gastrointestinal losses.
The nutritional status of the patients was assessed using the Subjective Global Assessment (SGA) technique [9] . Patients were accordingly categorized as Class A (well-nourished), B (moderately malnourished), and C (severely malnourished) [9] . Furthermore, a history of alcohol drinking of at least three drinks per day for more than 10 years, and a heavy alcohol intake in the preceding year was needed for the inclusion of alcohol as a potential cause of hypomagnesemia.
Prior to any therapeutic intervention, venous blood was obtained for the determination of serum glucose, urea, creatinine, uric acid, sodium (Na + [10] . The definitions of acid-base disorders have been described elsewhere [11] .
Analytical methods
Laboratory determinations were carried out by automated chemical analysis in our laboratory using an Olympus AU 600 analyser (Olympus Diagnostica, Hamburg, Germany), as previously described [12] . Arterial blood pH and PCO 2 were determined using a pH blood gas analyser: serum bicarbonate was calculated from blood pH and carbon dioxide tension according to the Henderson-Hasselbalch equation with an acidity exponent of 6.10 and solubility coefficient of 0.0301.
Statistical analysis
The results are expressed as means ± SD. Comparisons between individual groups were performed using Student's t-test or the nonparametric Mann-Whitney test. The chi-square (x 2 ) test was performed to assess differences in percentages. Comparisons across groups was performed by the one-way analysis of variance (ANOVA) followed by the LSD (least significant differences) test (in case of significant effects). Correlations between laboratory parameters were assessed with linear regression analysis. For non-normally distributed parameters (i.e. PTH) logarithmically transformed values were used for regression analysis. A p-value <0.05 was considered significant.
Results
Patient characteristics
One hundred and seven patients fulfilled the study inclusion criteria. Of those, fifty subjects (46.7%) were hypomagnesemic on hospital admission, and 57 (53.2%) during the course of their hospitalization. The majority of the study population (n = 66, 61.7%) was female and the mean age was 70.6 ± 14.3 (21-93) years. Only 20 patients were ≤65 years old. Moreover, 30 patients exhibited severe hypomagnesemia defined as serum Mg 2+ concentrations less than 1 mEq/L. These patients had lower serum levels of potassium and corrected calcium, and they exhibited a higher incidence of hypokalemia and true hypocalcemia as compared to those with serum Mg 2+ concentrations more than 1 mEq/L (0.5 mmol/L). It is worth mentioning that only six patients had serum Mg 2+ levels lower than 0.8 mEq/L. Mean age and biochemical characteristics of the study population are shown in table 1.
Taking into consideration that 2,284 patients were admitted to our clinic during the two-year study period, the incidence of hypоmagnesemia 
6.6 ± 0.9 6.3 ± 1 6.6 ± 0.9 Albumin (g/dL)
3.3 ± 0.7
1.05 ± 0.10 0.85 ± 0.09 1.13 ± 0.07** Phosphorus (mg/dL) 2.9 ± 0.9 2.8 ± 0.9 3.0 ± 0.9 Chloride (mEq/L) 101.7 ± 7.0 102.2 ± 6.5 101.5 ± 7.9 Parathyroid hormone (pg/mL) 81. The most common co-morbidities of the population studied were: diabetes mellitus (n = 43), infections (n = 42), hypertension (n = 35), cancer (n = 28), cirrhosis (n = 10, 7 of alcoholic origin), heart failure (n = 8), and stroke (n = 5).
In the majority of patients (n = 86, 80%) more than one condition may have contributed to the development of hypomagnesemia. Specifically, 53 (49.5%) patients were malnourished (of those 34 and 19 patients were moderately and severely malnourished, respectively), and 43 (40.1%) patients were diabetics [26 had uncontrolled diabetes with serum glucose levels >180 mg/dL (10 mmol/L)]. Other contributing factors for hypomagnesemia included respiratory alkalosis (n = 51, 47.7%), drugs [aminoglycosides (n = 23, 21.5%), thiazides (n = 20, 18.7%), furosemide (n = 17, 15.9%), cisplatin/carboplatin (n = 5, 4.6%), and amphotericin (n = 2, 1.8%)], diuretic phase of acute tubular necrosis (n = 29, 27.1%), alcohol consumption (n = 13, 12.1%), gastrointestinal losses (n = 11, 10.2%), and hypercalcemia [n = 6 (5.6%) due to malignancy (n = 4) and primary hyperparathyroidism (n = 2)]. Fortynine patients (45.8%) were receiving at least one of the aforementioned medications. All but one of these patients exhibited FEMg 2+ >4%. Furthermore, in all patients with uncontrolled diabetes mellitus, hypomagnesemia was accompanied by inappropriate magnesiuria. Diabetes was recognized as the single, potential cause of hypomagnesemia in nine cases. It is worth mentioning that 12 patients (11.2%) who also had at least one or more of the aforementioned potential causes of hypomagnesemia had also been on proton pump inhibitors (PPIs) for at least one month. The comparison of biochemical parameters of the study population according to age, nutritional status and the presence of diabetes is shown in tables 2-4 .
Concomitant electrolyte disturbances
Seventy one patients (66.3%) had at least one additional electrolyte disorder ( 
Acid-base disorders
Seventy-eight (72.9%) patients exhibited pure or mixed acid-base disorders (table 6). The main causes of respiratory alkalosis were: gramnegative septicemia, pulmonary disease (pneumonia, pulmonary thromboembolism), congestive heart failure, hepatic failure, and pain or anxiety-induced hyperventilation. Furthermore, metabolic acidosis was mainly attributed to renal failure, diarrhea, lactic acidosis, and ketoacidosis. Metabolic alkalosis was essentially related to loop or thiazide diuretic administration, hypokalemia and volume depletion. Finally, there were no differences in the incidence of acid-base disorders between patients with serum Mg 2+ levels < and ≥1 mEq/L (table 6).
Discussion
Hypomagnesemia is a frequent electrolyte disorder in hospitalized patients and its incidence varies considerably depending on the type of patient population studied and the definition of hypomagnesemia [1] [2] [3] . The incidence of hypomagnesemia in the current study was 4.7%, which does not differ substantially compared with previous studies using the same definition of hypomagnesemia [13, 14] . Moreover, the higher incidence of hypomagnesemia in patients aged >65 years (more than twice as compared to those aged ≤65 years) confirms previous reports regarding the strong association between aging and Mg 2+ deficit [15] .
The underlying causes of hypomagnesemia also range widely depending on the population at risk [3, 16, 17] . The present study involving patients hospitalized in an internal medicine clinic showed that the principal causes of hypomagnesemia were malnutrition, drugs (mainly diuretics and aminoglycosides), respiratory alkalosis, diabetes mellitus, acute tubular necrosis, alcohol consumption, and gastrointestinal losses. It should be emphasized that in the vast majority of cases, multiple risk factors for hypomagnesemia were present. Interestingly, our patients exhibited similar laboratory profiles regardless of age, nutritional status or the presence of diabetes. This lack of differences should be ascribed to the multifactorial nature of hypomagnesemia in this setting.
It is known that the regulation and fine-tuning of serum Mg 2+ concentration occurs primarily in the kidney. Indeed, in our study, serum Mg 2+ levels 2+ loss was of heterogenous and multifactorial origin. Among the potential factors associated with inappropriate magnesiuria, medications were more frequently involved. Specifically, thiazide and loop diuretics, as well as aminoglycosides, were involved in the majority of drug-related magnesiuria cases. Moreover, it has been reported that PPI-related hypomagnesemia is associated with long duration of use given that at least one year of drug administration is required [18] . In our study, despite the fact that PPIs were probably administered for a shorter time frame, at least in the majority of cases, a possible contributory role of these drugs could not be excluded. Of note, in a recent cross-sectional study, PPI therapy (of unknown duration) was also associated with an increased risk of hypomagnesemia [19] . Despite the lack of any correlation between serum Mg 2+ levels and arterial pH in our study, increased transcellular Mg 2+ shift from the extracellular to intracellular space may have contributed to the decreased serum Mg 2+ levels, especially in patients with alkalemia [20] .
It is well known that hypomagnesemia is frequently observed in diabetic patients [21, 22] . Accordingly in our study, diabetes, either as a single cause, or as a contributing factor, was evident in a considerable fraction of our patients. Osmotic diuresis accompanied by inappropriate magnesiuria, was the prominent, underlying mechanism of hypomagnesemia in our diabetic patients. It should be mentioned however, that glycated hemoglobin was not measured and therefore longterm diabetes control was not known in these patients. This study confirms previously described epidemiological features of the high incidence of concurrent electrolyte disorders in patients with hypomagnesemia [17, 23] . Indeed, almost two thirds of our patients exhibited at least one additional electrolyte disorder. Hypophosphatemia Table 6 . Acid-base disorders in the study population.
All patients (n = 107) was the most frequent electrolyte abnormality (31.1%), followed by hypokalemia (26.1%), hyponatremia (21.5%) and hypocalcemia (22%). Of note, severe hypomagnesemia was associated with higher incidence of hypokalemia and hypocalcemia. Several, interrelated mechanisms are implicated in the pathogenesis of the concurrent electrolyte disorders in hypomagnesemia [24] . Mg 2+ and K + depletion often occur together as the result of processes such as diuretic therapy and diarrhea that simultaneously induce negative balances in these two cations. Moreover, it is well established that hypomagnesemia of any cause produces K + depletion due to both urinary and fecal losses [25, 26] 2+ and associated electrolyte disorders [28] [29] [30] [31] . It is well recognized that hypomagnesemia is closely associated with hypocalcemia [17, 23] . Mg 2+ depletion leads to hypocalcemia largely because of impaired release of PTH or skeletal and renal tubules resistance to the action of PTH [32, 33] . In our study, corrected serum Ca 2+ concentration was inversely correlated with serum PTH levels, and concurrently a considerable percentage of hypocalcemic patients had PTH levels higher than the ULN. These findings are consistent with the hypothesis that the refractoriness of the target organs to PTH as opposed to diminished PTH secretion is of greater importance in most patients [34] . Our findings are also in agreement with the hypothesis that more severe hypomagnesemia (<0.8 mEq/L) is required for impaired release of PTH in the majority of cases [35] .
As far as hypophosphatemia is concerned, taking into consideration the absence of significant correlations between serum Mg 2+ and PO 4 3-levels, it should be ascribed mainly to underlying disorders that cause both Mg 2+ and PO 4 3- loss rather than to hypomagnesemia per se. In fact, it has been reported that Mg 2+ depletion only rarely leads to hypophosphatemia, although can cause renal phosphate wasting [36] . Consequently, other processes involved in the PO 4 3-homeostasis, such as increased gastrointestinal PO 4 3-losses, increased PO 4 3-entry into cells, poor PO 4 3-intake, hypokalemia-induced phosphaturia, and PO 4 3-wasting as part of the diffuse tubular dysfunction seen during the recovery from ATN, may have contributed to low serum PO 4 3-levels. The incidence of hyponatremia in our cohort was comparable with previous studies in which hyponatremia was frequently observed in hypomagnesemic patients and hypomagnesemia in hyponatremic patients [12, 17, 23] . For example, we have reported that in a series of 204 hyponatremic patients the incidence of hypomagnesemia was 15.2%. However, there was no direct association between Mg 2+ and Na + levels, a finding that was confirmed by the present study [12] . Consequently, the coexistence of hyponatremia and hypomagnesemia should be mainly attributed to the underlying causes (e.g. diuretics, malignancies, heart failure) that concurrently influence both Mg 2+ and water homeostasis. Finally, the frequent co-existence of diabetes and infections may have played a role in the development of hyponatremia in our study [37, 38] .
In conclusion, our study demonstrated the multifactorial nature of hypomagnesemia. Various pathophysiological factors, such as nutritional status, gastrointestinal absorption capacity, other co-morbid diseases or pharmacological agents, and acute illness, alone and in combination, play a key role. Finally, a wide array of concurrent acidbase and electrolyte disorders were observed in the majority of hypomagnesemic patients hospitalized in an internal medicine clinic.
Disclosure
Financial support: none. Conflict of interest: none.
